Quidel Corp. (NASDAQ:QDEL)’s share price fell 1.4% on Thursday . The stock traded as low as $21.52 and last traded at $21.55, with a volume of 60,290 shares trading hands. The stock had previously closed at $21.86.

Several brokerages have recently weighed in on QDEL. Zacks Investment Research upgraded Quidel Corp. from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research report on Wednesday, July 13th. Canaccord Genuity reiterated a “hold” rating and issued a $22.00 price target on shares of Quidel Corp. in a research report on Friday, July 29th. Raymond James Financial Inc. upgraded Quidel Corp. from a “market perform” rating to an “outperform” rating and set a $21.50 price target for the company in a research report on Monday, June 13th. Finally, TheStreet cut Quidel Corp. from a “hold” rating to a “sell” rating in a research report on Friday, May 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $21.58.

The firm’s market capitalization is $698.05 million. The stock’s 50 day moving average is $20.97 and its 200-day moving average is $17.90.

Quidel Corp. (NASDAQ:QDEL) last released its quarterly earnings data on Wednesday, July 27th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.14. During the same period last year, the company posted ($0.14) earnings per share. The business earned $39.10 million during the quarter, compared to the consensus estimate of $37.98 million. The business’s revenue was up 11.1% compared to the same quarter last year. On average, equities research analysts expect that Quidel Corp. will post ($0.14) EPS for the current fiscal year.

In other news, SVP Robert Joseph Bujarski sold 22,057 shares of the stock in a transaction on Tuesday, August 9th. The stock was sold at an average price of $22.58, for a total transaction of $498,047.06. Following the transaction, the senior vice president now directly owns 60,100 shares of the company’s stock, valued at approximately $1,357,058. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP John Tamerius sold 7,000 shares of the stock in a transaction on Monday, August 1st. The shares were sold at an average price of $23.02, for a total value of $161,140.00. Following the transaction, the senior vice president now directly owns 18,540 shares in the company, valued at $426,790.80. The disclosure for this sale can be found here.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.